BE903675Q - COMPOSITIONS CONTAINING 1,2,4-TRIAZOLE-3-CARBOXAMIDES AND THEIR METHOD OF USE - Google Patents

COMPOSITIONS CONTAINING 1,2,4-TRIAZOLE-3-CARBOXAMIDES AND THEIR METHOD OF USE

Info

Publication number
BE903675Q
BE903675Q BE0/215891A BE215891A BE903675Q BE 903675 Q BE903675 Q BE 903675Q BE 0/215891 A BE0/215891 A BE 0/215891A BE 215891 A BE215891 A BE 215891A BE 903675 Q BE903675 Q BE 903675Q
Authority
BE
Belgium
Prior art keywords
triazole
compositions containing
virus
carboxamides
thiocarboxamide
Prior art date
Application number
BE0/215891A
Other languages
French (fr)
Original Assignee
Vira Tek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US340332A external-priority patent/US3927216A/en
Application filed by Vira Tek Inc filed Critical Vira Tek Inc
Application granted granted Critical
Publication of BE903675Q publication Critical patent/BE903675Q/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Compositions contenant du 1,2,4-triazole-3-carboxamide, du 1,2,4-triazole-3-thiocarboxamide ou des sels physiologiquement compatibles de ceux-ci, pour inhiber le développement des infections provoquées par le virus de la grippe, sa forme para (parainfluenza) et l'herpès-virus chez des animaux à sang chaud, ainsi que le rhinovirus, le virus de la rougeole et le virus de la vaccine dans des cultures cellulaires, à titre d'agents antiviraux, et méthode d'utilisation de ces compositons.Compositions containing 1,2,4-triazole-3-carboxamide, 1,2,4-triazole-3-thiocarboxamide or physiologically compatible salts thereof, for inhibiting the development of infections caused by the influenza virus , its para (parainfluenza) form and herpes virus in warm-blooded animals, as well as rhinovirus, measles virus and vaccinia virus in cell cultures, as antiviral agents, and method of use of these compositons.

BE0/215891A 1973-03-12 1985-11-19 COMPOSITIONS CONTAINING 1,2,4-TRIAZOLE-3-CARBOXAMIDES AND THEIR METHOD OF USE BE903675Q (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US340332A US3927216A (en) 1971-06-01 1973-03-12 1,2,4-Triazol E-3-carboxamides for inhibiting virus infections

Publications (1)

Publication Number Publication Date
BE903675Q true BE903675Q (en) 1986-05-20

Family

ID=23332899

Family Applications (2)

Application Number Title Priority Date Filing Date
BE141915A BE812191A (en) 1973-03-12 1974-03-12 1,2,4-TRIAZOLE-3-CARBOXAMIDES AS ANTIVIRAL AGENTS
BE0/215891A BE903675Q (en) 1973-03-12 1985-11-19 COMPOSITIONS CONTAINING 1,2,4-TRIAZOLE-3-CARBOXAMIDES AND THEIR METHOD OF USE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BE141915A BE812191A (en) 1973-03-12 1974-03-12 1,2,4-TRIAZOLE-3-CARBOXAMIDES AS ANTIVIRAL AGENTS

Country Status (15)

Country Link
JP (2) JPS5836960B2 (en)
AR (1) AR205339A1 (en)
BE (2) BE812191A (en)
CH (1) CH602785A5 (en)
DE (1) DE2411823A1 (en)
ES (1) ES424201A1 (en)
FR (2) FR2221138B1 (en)
GB (1) GB1427304A (en)
IE (1) IE38987B1 (en)
IL (2) IL44394A0 (en)
LU (1) LU69626A1 (en)
NL (1) NL7403289A (en)
NO (1) NO138376C (en)
PH (1) PH12043A (en)
ZA (1) ZA741610B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2940654A1 (en) * 1979-10-06 1981-04-16 Bayer Ag, 5090 Leverkusen DIMERES KETEN OF 1,2 ,, - TRIAZOL-3-CARBONIC ACID
EP0034481B1 (en) * 1980-02-14 1984-05-30 Grigg, Ronald Ernest 2-methyl-5-thiazole-methylamine and carboxamide derivatives
KR840001959B1 (en) * 1980-04-23 1984-10-26 더 웰컴 파운데이숀 리미티드 Method for preparing 4-substituted-1-β-D-ribofuranyl-1H-imidazo- (4, 5-C) -pyridine
JPS57146593A (en) * 1981-03-09 1982-09-10 Ajinomoto Co Inc Preparation of ribofuranosyltriazole derivative
BE902199A (en) * 1984-10-29 1985-07-31 Vira Tek Inc METHOD OF MEDICAL TREATMENT OF VIRAL DISEASES USING 1-BETA-D-RIBOFURANNOSYL-1, 2,4-TRIAZOLE-3-CARBOXAMIDE.
JPS62165096A (en) * 1986-01-14 1987-07-21 Hitachi Ltd Refueling device
EP2201953A4 (en) 2007-08-27 2011-08-03 Univ Nagoya Nat Univ Corp USE OF RIBAVIRIN IN BLOOD COAGULATION DISORDER
JPWO2009028575A1 (en) 2007-08-27 2010-12-02 国立大学法人名古屋大学 Activator of blood coagulation factor VII promoter and use thereof

Also Published As

Publication number Publication date
IE38987B1 (en) 1978-07-05
NO740841L (en) 1974-09-13
LU69626A1 (en) 1974-08-06
NO138376B (en) 1978-05-16
FR2221138B1 (en) 1978-07-28
AU6670874A (en) 1975-09-18
JPS5915886B2 (en) 1984-04-12
FR2289520A1 (en) 1976-05-28
IL52848A0 (en) 1977-10-31
CH602785A5 (en) 1978-08-15
ZA741610B (en) 1975-02-26
NO138376C (en) 1978-08-23
JPS5029720A (en) 1975-03-25
NL7403289A (en) 1974-09-16
PH12043A (en) 1978-10-18
ES424201A1 (en) 1976-05-01
JPS5836960B2 (en) 1983-08-12
BE812191A (en) 1974-07-01
FR2289520B1 (en) 1978-05-12
IL44394A0 (en) 1974-06-30
DE2411823A1 (en) 1974-09-26
IE38987L (en) 1974-09-12
FR2221138A1 (en) 1974-10-11
AR205339A1 (en) 1976-04-30
JPS58219115A (en) 1983-12-20
GB1427304A (en) 1976-03-10

Similar Documents

Publication Publication Date Title
PT933993E (en) SUBSTITUTED CYCLOPENTANEUS COMPOUNDS, UTEIS AS NEURAMINIDASE INHIBITORS
FI20001231A7 (en) 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives and their analogues and their use as antiviral agents
EA199901031A1 (en) Derivatives of benzimidazole
EA200200471A1 (en) CONDENSED NAFTYRIDINES AS HIV Reverse Transcriptase Inhibitors
PA8432901A1 (en) PIRIDILPIRROL COMPOUNDS
ES2070276T3 (en) CELL GROWTH INHIBITOR MACROCYCLIC LACTONS CALLED COMBRETASTATIN D-2.
Bauer A history of the discovery and clinical application of antiviral drugs
DK92781A (en) PROCEDURE FOR THE PREPARATION OF INDANDER DERIVATIVES OR ACID ADDITION SALTS THEREOF
BR9813651A (en) Antipicornoviral compounds and methods for their use and preparation
ATE116637T1 (en) SULFONIC STILBEN DERIVATIVES FOR THE TREATMENT OF VIRUS DISEASES.
FR2432500A1 (en) NOVEL BENZENE PROPANAMINE DERIVATIVES AND SALTS THEREOF, PROCESS FOR THEIR PREPARATION AND APPLICATION AS MEDICAMENTS
ES2045182T3 (en) PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCESS FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
BE903675Q (en) COMPOSITIONS CONTAINING 1,2,4-TRIAZOLE-3-CARBOXAMIDES AND THEIR METHOD OF USE
DK208987D0 (en) POLYPEPTIDES AND ANTIBODIES CHARACTERISTIC FOR PAPILLOMVIRUS AND THEIR USE IN DIAGNOSTIC METHODS AND IN VACCINES
TNSN90021A1 (en) PROCESS FOR THE PREPARATION OF TETRAHYDROIMIDAZO (1,4) BENZODIAZEPIN -2- ANTIVIRAL THIONES
BR9916669A (en) Use of derivatives of substituted 4-biarylbutyric and 5-biarylpentanoic acids as matrix metalloprotease inhibitors for the treatment of respiratory diseases
GB1334327A (en) Compositions for and method of combating virus infections
FR2363608A1 (en) PROCESS FOR PREPARING "BISAZOIC" COLORANTS
SE8303136D0 (en) LOOXAZOLIDINONE-2 N-ARYLEE OPTIFICATION OPERATIONS, SPECIFIC INHIBITORS AND REVERSIBILITIES OF TYPE B MONOAMINE OXYDASE AND THEIR PREPARATION PROCEDURE
DK601683A (en) DIALKYLAMINOALCOXYBENZYL ALCOHOL DERIVATIVES
AR002758A1 (en) OLIGONUCLEOTIDES SPECIFIC FOR HUMAN PAPILOMA VIRUSES, THE PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, THE USE OF OLIGONUCLEOTIDES, A KIT FOR THE DETECTION AND THE METHOD FOR SUCH DETECTION.
DK313587D0 (en) TETRAHYDROBENZOTHIAZOL COMPOUNDS, THEIR PREPARATION AND USE
Rich et al. Growth Inhibition of Chick-Embryo Cells by Some 5-Fluorinated Pyrimidiness: Effect on Rous Sarcoma Virus Infection
SE8203856D0 (en) NOVEL DERIVATIVES OF GUANINE II
BRPI0012329B8 (en) benzofuran derivatives, process for their preparation and their use.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: VIRATEK INC.

Effective date: 19951130